Evidence map›Paper›PMID 36710156›Full record

ArticleZeitschrift fur medizinische Physik2023

Feasibility of radiomic feature harmonization for pooling of [

Adrian Jun Zounek, Nathalie Lisa Albert, Adrien Holzgreve, Marcus Unterrainer, Julia Brosch-Lenz, Simon Lindner, Andreas Bollenbacher, Guido Boening, Rainer Rupprecht, Matthias Brendel and 5 more

Open access · goldAbstract read
In one paragraph

Article in Zeitschrift fur medizinische Physik, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Applications of artificial intelligence in nuclear medicine.Zeitschrift fur medizinische Physik · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cancers · 2023
    Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Adrian Jun ZounekDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: adrian.zounek@med.uni-muenchen.de.
Nathalie Lisa AlbertDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany. Electronic address: nathalie.albert@med.uni-muenchen.de.
Adrien HolzgreveDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: adrien.holzgreve@med.uni-muenchen.de.
Marcus UnterrainerDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; Department of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: marcus.unterrainer@med.uni-muenchen.de.
Julia Brosch-LenzDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: julia.brosch-lenz@med.uni-muenchen.de.
Simon LindnerDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: simon.lindner@med.uni-muenchen.de.
Andreas BollenbacherDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: andreas.bollenbacher@med.uni-muenchen.de.
Guido BoeningDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: guido.boening@med.uni-muenchen.de.
Rainer RupprechtDepartment of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany. Electronic address: rainer.rupprecht@medbo.de.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany. Electronic address: matthias.brendel@med.uni-muenchen.de.
Louisa von BaumgartenBavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany; Department of Neurosurgery, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: louisa.vonbaumgarten@med.uni-muenchen.de.
Joerg-Christian TonnGerman Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department of Neurosurgery, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: Joerg.Christian.Tonn@med.uni-muenchen.de.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Electronic address: peter.bartenstein@med.uni-muenchen.de.
Sibylle ZieglerDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: sibylle.ziegler@med.uni-muenchen.de.
Lena KaiserDepartment of Nuclear Medicine, University Hospital, LMU Munich, 81377 Munich, Germany. Electronic address: Lena.Kaiser@med.uni-muenchen.de.
Ludwig-Maximilians-Universität München · DELMU Klinikum · DEHeidelberg University · DEUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLarge datasets are required to ensure reliable non-invasive glioma assessment with radiomics-based machine learning methods. This can often only be achieved by pooling images from different centers. Moreover, trained models should perform with high accuracy when applied to data from different centers. In this study, the impact of reconstruction settings and segmentation methods on radiomic features derived from amino acid and TSPO PET images of glioma patients was examined. Additionally, the ability to model and thus reduce feature differences was investigated.

methods[

resultsAccording to Friedman analyses, most features (>60%) showed significant differences. Yet, CV and inter-rater reliability measures indicated higher robustness. ComBat resulted in almost complete harmonization (>87%) according to Friedman test and little to no improvement according to CV and inter-rater reliability measures. [

conclusionsAccording to Friedman test, feature distributions could be successfully aligned using ComBat. However, depending on settings, changes in patient ranks were observed for some features and could not be eliminated by harmonization. Thus, for clinical utilization it is recommended to exclude affected features.

Indexed as

GliomaPositron-Emission TomographyCarbazolesFeasibility StudiesHumansReceptors, GABAReproducibility of ResultsCarbazolesGE-180Receptors, GABATSPO protein, humanData PoolingFET PETGliomaRadiomicsRobustnessTSPO PET

Identifiers

PMID36710156
PMCPMC10068577
OpenAlexW4318542421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.